MS Canada

Corporate details

Corporation number

14146379

Business number

107746174

Status

Active

Governing law

Canada Not-for-profit Corporations Act

Formed

Jan 1, 2023

Registered office

250 Dundas Street West
Suite 500
Toronto ON M5T 2Z5

Number of directors

At least 12, at most 17As the articles allow.

Annual filings

Anniversary date

Jan 1The date of incorporation, amalgamation or continuance.

Annual filing period

Jan 1 to Mar 2 each year

Last annual meeting

Jun 27, 2025

The last annual return filed, and each year since.

Directors

Loading the directors from the federal record...

Registered charity

Charity registration number

107746174RR0001

Designation

Charitable organization

Category

Core health care

Total revenue

$41,079,240Fiscal period ended Dec 31, 2024.

Total expenditures

$41,112,157

From its annual return to the Canada Revenue Agency (form T3010). Its charity page has its programs, finances and gifts.

Federal grants and contributions

39 agreements since 2017, worth $287,935 in all.

As each federal department publishes them (proactive disclosure). A value is the agreement's total as last amended; the money may be paid over several years. The 10 most recent are shown. Search every federal grant.

Lobbying the federal government

Registered to lobby the federal government now, and first registered in 2024.

Registrations

4Each consultant hired, and its own in-house registration, is a registration of its own.

Who lobbies

Consultant lobbyists

Institutions lobbied

House of Commons, Prime Minister's Office (PMO), Accessibility Standards Canada, Atlantic Canada Opportunities Agency (ACOA), Canada Employment Insurance Commission, Canada Post Corporation (CPC), Canada Revenue Agency (CRA), Canadian Heritage (PCH), Canadian Human Rights Commission (CHRC), Canadian Institutes of Health Research (CIHR)The ten named most often.

In its latest registration, in its own words

• Canadian Institutes of Health Research (CIHR) as it relates to federal funding & long term investment in health research.
• Access to treatments as it relates to the current regulatory and price negotiation processes to enhance timely access to all Health Canada approved Mutiple Sclerosis (MS) disease-modifying therapies, with respect to the National Strategy for Drugs for Rare Diseases and national pharmacare.
• We ask the federal government to fund MS research in partnership with MS Canada, leveraging our connections and expertise to focus and further our understanding of MS, pursue leading-edge research on repair and regeneration, and explore prevention strategies, including targeting the Epstein-Barr...

From the Registry of Lobbyists (Office of the Commissioner of Lobbying), which lists the client as “MS Canada”. Shown here because the client's name is this corporation's exact name, and its postal area matches this corporation's registered office. The names of lobbyists and of the officials they met are left out. Contains information licensed under the Open Data Licence Agreement – Office of the Commissioner of Lobbying. Not this company? Tell us.